ReVision Implant
ReVision Implant45About
What does ReVision Implant do?
ReVision Implant is developing a breakthrough cortical implant technology that bypasses the eye to restore vision by delivering visual information directly to the brain. Their visual prosthesis uses thousands of micro-electrodes wirelessly linked to a headset, enabling blind individuals to regain useful vision. This technology aims to help tens of millions worldwide affected by blindness, particularly those with retinal damage for whom current therapies are unavailable.
What is ReVision Implant's valuation?
StartupHub estimates ReVision Implant's effective valuation at $54.6M (range $35.0M to $84.0M, 21% confidence), based on comparable companies in the sector.
How much funding has ReVision Implant raised?
ReVision Implant has raised a total of $14M in funding. The most recent round on record is Funding Round.
Where is ReVision Implant headquartered?
ReVision Implant is headquartered in Leuven, Belgium.
When was ReVision Implant founded?
ReVision Implant was founded in 2017.
What industry does ReVision Implant operate in?
ReVision Implant operates in Neurotechnology, Medical Devices, Biotechnology, Healthcare, Neurotech, MedTech.
Designs, manufactures, and markets medical devices for diabetes care, wound care, and drug delivery.
Governed Intelligence for safety-critical engineering environments.
Aidcompany is a company that imports and distributes medical devices and technological solutions for people with reduced mobility.
Marketmedtech is a startup focused on providing innovative solutions within the medical technology sector.
An entrant is a company tagged Medical Devices whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.